| Accession Number: | 0001209191-20-010554 |
| Date: | 2020-02-17 |
| Issuer: | VERTEX PHARMACEUTICALS INC / MA (VRTX) |
| Original Submission Date: |
SILVA PAUL M
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON, MA 02210
| Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
|---|---|---|---|---|---|---|---|---|---|
| COMMON STOCK | 2020-02-17 | F | 1,248 | d | $241.50 | 18,440 | direct | ||
| COMMON STOCK | 2020-02-18 | S | 240 | d | $241.95 | 18,200 | direct | ||
| COMMON STOCK | 2020-02-18 | S | 640 | d | $242.80 | 17,560 | direct | ||
| COMMON STOCK | 2020-02-18 | S | 202 | d | $243.85 | 17,358 | direct | ||
| COMMON STOCK | 2020-02-18 | S | 280 | d | $245.00 | 17,078 | direct | ||
| COMMON STOCK | 2020-02-18 | S | 202 | d | $245.74 | 16,876 | direct | ||
| COMMON STOCK | 2020-02-17 | 0 | $0.00 | 169 | indirect |
| Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
|---|
| ID | footnote |
|---|---|
| f1 | transaction made pursuant to mr. silva's company approved trading plan under rule 10b5-1. |
| f2 | open market sales reported on this line occurred at a weighted average price of $241.95 (range $241.43 to $242.40). |
| f3 | mr. silva undertakes to provide (upon request by the sec staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |
| f4 | open market sales reported on this line occurred at a weighted average price of $242.80 (range $242.45 to $243.32). |
| f5 | open market sales reported on this line occurred at a weighted average price of $243.85 (range $243.52 to $244.29). |
| f6 | open market sales reported on this line occurred at a weighted average price of $245.00 (range $244.52 to $245.43.) |
| f7 | open market sales reported on this line occurred at a weighted average price of $245.74 (range $245.55 to $245.86.) |
